Key metrics and charts across all fundamental categories.
Stock price and market valuation
BBIO trades at $69.36, a 100.6% increase year-over-year. Market capitalization stands at $13.51B, up 105.5% from the prior year. Track BBIO price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$579.96M in TTM revenue grew 355.2% YoY, reaching $194.51M last quarter. TTM EBITDA of $-516.94M on operating income of $-105.96M shows growth is flowing through. However, net income is negative at $729.88M — growth is not yet reaching the bottom line. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
Price multiples and return ratios
P/S of 23.3x and P/B of 0.0x. A high P/S suggests growth expectations are priced in.
Operating efficiency and return metrics
Op. margin of -54.5% is up 35.0% YoY — cost efficiency is improving. Net margin at -85.6% and gross margin of 94.9%.
Free cash flow, earnings quality, and capital allocation
FCF of $-197.35M on $-197.28M in operating cash flow. The FCF / Net Income ratio of 0.3x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $879.89M provide financial flexibility. Shares outstanding rose 2.4% YoY — shareholder dilution is eroding per-share value.
